American Urological Association Free Prostate Cancer Webinar Series

In 2008, the AUA will offer a free series of Webinars on a variety of topics related to prostate cancer. These expert-led webinars were designed for medical professionals who treat prostate cancer. Each 30-minute webinar program will be broadcast live beginning at 8:00 p.m. ET, with a 15-minute question and answer session immediately following the presentation. Attendance for the live event is limited. Each individual program will be recorded and available on line for downloading the day after the live event. Earn 0.5 hours of AMA PRA Category 1 Credits^TM for each webinar activity.

To register for a live event or download a recorded program, click on the appropriate button below. To take a posttest following the course, log in here.

April 16, 2008 Robotic vs. Open Prostatectomy: The Real Story Joseph A. Smith, MD
June 25, 2008 Advances in Radiation Therapy for Localized Prostate Cancer Michael J. Zelefsky, MD
July 23, 2008 Strategies for Salvage Therapy: When and What? Christopher J. Kane, MD
August 20, 2008 Minimal Disease on Systematic TRUS Biopsy: What Next? Judd W. Moul, MD
September 3, 2008 Prostate Cancer Prevention: Is There Something We Can Do? Ian M. Thompson, MD
September 10, 2008 Understanding and Defining Risk Eric A. Klein, MD
September 17, 2008 Role of Complementary Medicine in Prostate Cancer Stephen Y. Nakada, MD
September 24, 2008 Screening for Prostate Cancer: Where Are We and Where Should We Go? H. Ballantine Carter, MD
October 22, 2008 Interpreting the Pathology Report: What Does it Mean for Our Patients? Jonathan I. Epstein, MD
November 19, 2008 New Paradigms in the Treatment of the High Risk Patient Louis Potters, MD
December 10, 2008 Potency Following Radiation, Surgery or Hormones John P. Mulhall, MD

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AUA takes responsibility for the content, quality, and scientific integrity of this CME activity.

Credit Designation: The American Urological Association designates this educational series for a maximum of 5.5 AMA PRA Category 1 Credits^TM or each webinar activity for 0.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AUA Disclosure Policy: As a provider accredited by the ACCME, the AUA must insure balance, independence, objectivity and scientific rigor in all its activities.

All faculty participating in an educational activity provided by the AUA are required to disclose to the audience any relevant financial relationships with any commercial interest to the provider. The intent of this disclosure is not to prevent faculty with relevant financial relationships from serving as faculty, but rather to provide members of the audience with information on which they can make their own judgments. The AUA must resolve any conflicts of interest prior to the commencement of the educational activity. It remains for the audience to determine if the faculty’s relationships may influence the educational content with regard to exposition or conclusion. When unlabeled or unapproved uses are discussed, these are also indicated.

Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to unlabeled or unapproved uses or drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.